Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-10-05
1998-06-02
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530329, 530330, A61K 3800, C07K 706, C07K 700
Patent
active
057600023
ABSTRACT:
The subject invention involves anti-inflammatory compounds having the following structure: ##STR1## wherein: a) --X is cyclic alkyl, having from 4 to 15 carbon atoms; branched alkyl, having from 6 to 15 carbon atoms; or aryl having from 6 to 15 carbon atoms;
(b) n is an integer from 0 to 2;
(c) --V-- is --OC(O)--, --N(Q)C(O)--, --N(Q)C(S)--, --C(O)--, --SO2-- or --P(O)(OH)--;
(d) --Q is hydrogen; or straight or branched chain alkyl, saturated or unsaturated with 1 or 2 double bonds, having from 1 to 6 carbon atoms; or --Q and --X are covalently linked forming a cyclic moiety which includes the nitrogen to which --Q is bonded and from 5 to 20 carbon atoms;
(e) Z is --O-- or --NH--; when V is --OC(O)--, --Z-- is --NH--;
(f) --R1 is a hydrophobic moiety;
(g) --R2 is a hydrophobic moiety;
(h) --R3 is --(CH2)m--A--NH2 or --(CH2)m--A--B--C(NH2).dbd.NH wherein m is an integer from 1 to about 6, --A--is a covalent bond or p-phenyl or p-cyclohexyl, and --B-- is a covalent bond or --NH--;
(i) --R4 is a hydrophobic moiety;
(j) --R5 is --(CH2)m--A--NH2 or --(CH2)m--A--B--C(NH2).dbd.NH wherein m is an integer from 1 to about 6, --A-- is a covalent bond or p-phenyl or p-cyclohexyl, and --B-- is a covalent bond or --NH--; and
(k) --Y is hydrogen or methyl.
The subject invention also involves pharmaceutical compositions comprising the above compounds, and methods for treating inflammation or pain using such compounds and compositions.
REFERENCES:
patent: 4242329 (1980-12-01), Claeson et al.
patent: 4316889 (1982-02-01), Bajusz et al.
patent: 4399065 (1983-08-01), Bajusz et al.
patent: 4401594 (1983-08-01), Umezawa et al.
patent: 4478745 (1984-10-01), Bajusz et al.
patent: 4528133 (1985-07-01), Kasafirek et al.
patent: 4596789 (1986-06-01), Dutta et al.
patent: 4623639 (1986-11-01), Hassall et al.
patent: 4703036 (1987-10-01), Bajusz et al.
patent: 4816449 (1989-03-01), Hahn
patent: 4845242 (1989-07-01), Powers et al.
patent: 4873221 (1989-10-01), Trainor
patent: 4880780 (1989-11-01), Trainor et al.
patent: 4883863 (1989-11-01), Abe et al.
patent: 4902781 (1990-02-01), Mizoue et al.
patent: 4923890 (1990-05-01), Trainor et al.
patent: 5036054 (1991-07-01), Kaltenbronn et al.
patent: 5066642 (1991-11-01), Vranesic et al.
patent: 5066643 (1991-11-01), Abeles et al.
Aoyagi, et al. "Biological Activities of Leupeptins", The Journal of Antibiotics, vol. 22, pp. 558-568 (1969).
Bajusz, et al. "Inhibition of Thrombin and Trypsin by Tripeptide Aldehydes", Int. J. Peptide Protein Res., vol. 12, pp. 217-221 (1978).
Gaal, et al. "Cationic Ferritin Uptake by Cultured Anterior Pituitary Cells Treated with the Proteinase Inhibitor, BOC-DPhe-Phe-Lys-H", Histochemistry, vol. 88, pp. 401-406 (1988).
Makara, et al. "The Tripeptide Aldehyde, Boc-DPhe-Phe-Lysinal, is a Novel Ca.sup.2+ Channel Inhibitor in Pituitary Cells", European Journal of Pharmacology, vol. 151, pp. 147-149 (1988).
Nagy, et al. "Tripeptide Aldehyde Protease Inhibitors May Depress in Vitro Prolactin and Growth Hormone Release", Endocrinology, vol. 116, pp. 1426-1432 (1985).
Rappay, et al. "Various Proteinase Inhibitors Decrease Prolactin and Growth Hormone Release by Anterior Pituitary Cells", Life Sciences, vol. 36, pp. 549-555 (1985).
Hersko Bart S.
Marshall S. G.
Rasser Jacobus C.
Suter David L.
The Proctor & Gamble Company
LandOfFree
Diflouro pentapeptide derivative anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diflouro pentapeptide derivative anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diflouro pentapeptide derivative anti-inflammatory agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1459799